TY - JOUR AU - Akiyama, T. AU - Sudo, C. AU - Ogawara, H. AU - Toyoshima, K. AU - Yamamoto, T. PY - 1986 DA - 1986// TI - The product of the c-erbB-2 gene: a 185-kilodalton glycoprotein with tyrosine kinase activity JO - Science VL - 232 UR - https://doi.org/10.1126/science.3012781 DO - 10.1126/science.3012781 ID - Akiyama1986 ER - TY - JOUR AU - Hynes, N. E. AU - Stern, D. F. PY - 1994 DA - 1994// TI - The biology of erbB-2/neu/HER-2 and its role in cancer JO - Biochim Biophys Acta VL - 1198 ID - Hynes1994 ER - TY - JOUR AU - Nagai, M. A. AU - Pacheco, M. M. AU - Oshima, C. T. AU - Brentani, M. M. PY - 1993 DA - 1993// TI - c-erbB-2 DNA amplification and mRNA expression in human primary breast tumors and its relationship to other prognostic factors JO - Cancer Biother VL - 8 UR - https://doi.org/10.1089/cbr.1993.8.29 DO - 10.1089/cbr.1993.8.29 ID - Nagai1993 ER - TY - JOUR AU - Pauletti, G. AU - Godolphin, W. AU - Press, M. F. AU - Slamon, D. J. PY - 1996 DA - 1996// TI - Detection and quantitation of HER-2/neu gene amplification in human breast cancer archival material using fluorescence in situhybridization JO - Oncogene VL - 13 ID - Pauletti1996 ER - TY - JOUR AU - Hoang, M. P. AU - Sahin, A. A. AU - Ordonez, N. G. AU - Sneige, N. PY - 2000 DA - 2000// TI - HER-2/neu gene amplification compared with HER-2/neu protein overexpression and interobserver reproducibility in invasive breast carcinoma JO - Am J Clin Pathol VL - 113 UR - https://doi.org/10.1309/VACP-VLQA-G9DX-VUDF DO - 10.1309/VACP-VLQA-G9DX-VUDF ID - Hoang2000 ER - TY - JOUR AU - Tubbs, R. R. AU - Pettay, J. AU - Roche, P. AU - Stoler, M. H. AU - Jenkins, R. AU - Myles, J. AU - Grogan, T. PY - 2000 DA - 2000// TI - Concomitant oncoprotein detection with fluorescence in situ hybridization (CODFISH). A fluorescence-based assay enabling simultaneous visualization of gene amplification and encoded protein expression JO - J Mol Diagn VL - 2 UR - https://doi.org/10.1016/S1525-1578(10)60620-4 DO - 10.1016/S1525-1578(10)60620-4 ID - Tubbs2000 ER - TY - JOUR AU - Vaziri, S. A. J. AU - Tubbs, R. R. AU - Darlington, G. AU - Casey, G. PY - 2001 DA - 2001// TI - Absence of CCND1 gene amplification in breast tumours of BRCA1 mutation carriers JO - Mol Pathol VL - 54 UR - https://doi.org/10.1136/mp.54.4.259 DO - 10.1136/mp.54.4.259 ID - Vaziri2001 ER - TY - JOUR AU - Slamon, D. J. AU - Godolphin, W. AU - Jones, L. A. AU - Holt, J. A. AU - Wong, S. G. AU - Keith, D. E. AU - Levin, W. J. AU - Stuart, S. G. AU - Udove, J. AU - Ullrich, A. PY - 1989 DA - 1989// TI - Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer JO - Science VL - 244 UR - https://doi.org/10.1126/science.2470152 DO - 10.1126/science.2470152 ID - Slamon1989 ER - TY - JOUR AU - Budman, D. R. AU - Berry, D. A. AU - Cirrincione, C. T. AU - Henderson, I. C. AU - Wood, W. C. AU - Weiss, R. B. AU - Ferree, C. R. AU - Muss, H. B. AU - Green, M. R. AU - Norton, L. PY - 1998 DA - 1998// TI - Dose and dose intensity as determinants of outcome in the adjuvant treatment of breast cancer. The Cancer and Leukemia Group B JO - J Natl Cancer Inst VL - 90 UR - https://doi.org/10.1093/jnci/90.16.1205 DO - 10.1093/jnci/90.16.1205 ID - Budman1998 ER - TY - JOUR AU - De Laurentiis, M. AU - Arpino, G. AU - Massarelli, E. AU - Ruggiero, A. AU - Carlomagno, C. AU - Tortora, G. AU - Ciardiello, F. AU - Bianco, A. R. AU - De Placido, S. PY - 2002 DA - 2002// TI - HER2 as predictive marker of resistance to endocrine treatment (ET) for advanced breast cancer (ABC): a metanalysis of published studies [abstract] JO - Breast Cancer Res Treat VL - 76 ID - De Laurentiis2002 ER - TY - JOUR AU - Hanna, W. PY - 2001 DA - 2001// TI - Testing for HER2 status JO - Oncology VL - 61 UR - https://doi.org/10.1159/000055398 DO - 10.1159/000055398 ID - Hanna2001 ER - TY - JOUR AU - Lebeau, A. AU - Deimling, D. AU - Kaltz, C. AU - Sendelhofert, A. AU - Iff, A. AU - Luthardt, B. AU - Untch, M. AU - Lohrs, U. PY - 2001 DA - 2001// TI - Her-2/neu analysis in archival tissue samples of human breast cancer: comparison of immunohistochemistry and fluorescence in situ hybridization JO - J Clin Oncol VL - 19 ID - Lebeau2001 ER - TY - JOUR AU - Leitzel, K. AU - Teramoto, Y. AU - Konrad, K. AU - Chinchilli, V. M. AU - Volas, G. AU - Grossberg, H. AU - Harvey, H. AU - Demers, L. AU - Lipton, A. PY - 1995 DA - 1995// TI - Elevated serum c-erbB-2 antigen levels and decreased response to hormone therapy of breast cancer JO - J Clin Oncol VL - 13 ID - Leitzel1995 ER - TY - JOUR AU - Piccart, M. AU - Lohrisch, C. AU - Di Leo, A. AU - Larsimont, D. PY - 2001 DA - 2001// TI - The predictive value of HER2 in breast cancer JO - Oncology VL - 61 UR - https://doi.org/10.1159/000055405 DO - 10.1159/000055405 ID - Piccart2001 ER - TY - JOUR AU - Slamon, D. J. AU - Leyland-Jones, B. AU - Shak, S. AU - Fuchs, H. AU - Paton, V. AU - Bajamonde, A. AU - Fleming, T. AU - Eiermann, W. AU - Wolter, J. AU - Pegram, M. AU - Baselga, J. AU - Norton, L. PY - 2001 DA - 2001// TI - Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2 JO - N Engl J Med VL - 344 UR - https://doi.org/10.1056/NEJM200103153441101 DO - 10.1056/NEJM200103153441101 ID - Slamon2001 ER - TY - JOUR AU - Marty, M. AU - Cognetti, F. AU - Maraninchi, D. AU - Snyder, R. AU - Mauriac, L. AU - Tubiana-Hulin, M. AU - Chan, S. AU - Grimes, D. AU - Antón, A. AU - Lluch, A. PY - 2005 DA - 2005// TI - Efficacy and safety of trastuzumab combined with docetaxel in patients with HER2-positive metastatic breast cancer given as first-line treatment: results of a randomized phase II trial (M77001) JO - J Clin Oncol VL - 23 UR - https://doi.org/10.1200/JCO.2005.04.173 DO - 10.1200/JCO.2005.04.173 ID - Marty2005 ER - TY - JOUR AU - Baselga, J. PY - 2001 DA - 2001// TI - Herceptin alone or in combination with chemotherapy in the treatment of HER2-positive metastatic breast cancer: pivotal trials JO - Oncology VL - 61 UR - https://doi.org/10.1159/000055397 DO - 10.1159/000055397 ID - Baselga2001 ER - TY - JOUR AU - Bilous, M. AU - Dowsett, M. AU - Hanna, W. AU - Isola, J. AU - Lebeau, A. AU - Moreno, A. AU - Penault-Llorca, F. AU - Ruschoff, J. AU - Tomasic, G. AU - van de Vijver, M. PY - 2003 DA - 2003// TI - Current perspectives on HER2 testing: a review of national testing guidelines JO - Mod Pathol VL - 16 UR - https://doi.org/10.1097/01.MP.0000052102.90815.82 DO - 10.1097/01.MP.0000052102.90815.82 ID - Bilous2003 ER - TY - JOUR AU - Isola, J. AU - Tanner, M. AU - Forsyth, A. AU - Cooke, T. G. AU - Watters, A. D. AU - Bartlett, J. M. PY - 2004 DA - 2004// TI - Interlaboratory comparison of HER-2 oncogene amplification as detected by chromogenic and fluorescence in situ hybridization JO - Clin Cancer Res VL - 10 UR - https://doi.org/10.1158/1078-0432.CCR-0428-03 DO - 10.1158/1078-0432.CCR-0428-03 ID - Isola2004 ER - TY - JOUR AU - Tanner, M. AU - Gancberg, D. AU - Di Leo, A. AU - Larsimont, D. AU - Rouas, G. AU - Piccart, M. J. AU - Isola, J. PY - 2000 DA - 2000// TI - Chromogenic in situ hybridisation: a practical alternative for fluorescence in situ hybridisation to detect HER-2/neuoncogene amplification in archival breast cancer samples JO - Am J Pathol VL - 157 UR - https://doi.org/10.1016/S0002-9440(10)64785-2 DO - 10.1016/S0002-9440(10)64785-2 ID - Tanner2000 ER - TY - JOUR AU - Zhao, J. AU - Wu, R. AU - Au, A. AU - Marquez, A. AU - Yu, Y. AU - Shi, Z. PY - 2002 DA - 2002// TI - Determination of HER2 gene amplification by chromogenic in situ hybridization (CISH) in archival breast carcinoma JO - Mod Pathol VL - 15 UR - https://doi.org/10.1038/modpathol.3880582 DO - 10.1038/modpathol.3880582 ID - Zhao2002 ER - TY - JOUR AU - Dandachi, N. AU - Dietze, O. AU - Hauser-Kronberger, C. PY - 2002 DA - 2002// TI - Chromogenic in situ hybridisation: a novel approach to a practical and sensitive method for the detection of HER2 oncogene in achival human breast carcinoma JO - Lab Invest VL - 82 UR - https://doi.org/10.1097/01.LAB.0000024360.48464.A4 DO - 10.1097/01.LAB.0000024360.48464.A4 ID - Dandachi2002 ER - TY - JOUR AU - Arnould, L. AU - Denoux, Y. AU - MacGrogan, G. AU - Penault-Llorca, F. AU - Fiche, M. AU - Treilleux, I. AU - Mathieu, M. C. AU - Vincent-Salomon, A. AU - Vilain, M. O. AU - Couturier, J. PY - 2003 DA - 2003// TI - Agreement between chromogenic in situ hybridisation (CISH) and FISH in the determination of HER2 status in breast cancer JO - Br J Cancer VL - 88 UR - https://doi.org/10.1038/sj.bjc.6600943 DO - 10.1038/sj.bjc.6600943 ID - Arnould2003 ER - TY - STD TI - Tubbs R, Pettay J, Skacel M, Hicks D, Mele J, Powell R, Chen T, Nita H, Grogan T, Hainfeld J: Automated chromogenic in situ hybridization (CISH) for detection of HER2 gene amplification. USACAP (poster 17). March 25, 2003 ID - ref24 ER - TY - JOUR AU - Mass, R. AU - Sanders, C. AU - Kasian, C. AU - Johnson, L. AU - Everett, T. AU - Anderson, S. PY - 2000 DA - 2000// TI - The concordance between the clinical trials assay (CTA) and fluorescence in situ hybridization (FISH) in the Herceptin pivotal trials JO - Proc Am Soc Clin Oncol VL - 19 ID - Mass2000 ER - TY - JOUR AU - Tsuda, H. AU - Akiyama, F. AU - Terasaki, H. AU - Hasegawa, T. AU - Kurosumi, M. AU - Shimadzu, M. AU - Yamamori, S. AU - Sakamoto, G. PY - 2001 DA - 2001// TI - Detection of HER-2/neu (c-erb B-2) DNA amplification in primary breast carcinoma. Interobserver reproducibility and correlation with immunohistochemical HER-2 overexpression JO - Cancer VL - 92 UR - https://doi.org/3.0.CO;2-A DO - 3.0.CO;2-A ID - Tsuda2001 ER - TY - JOUR AU - Isola, J. AU - Tanner, M. AU - Forsyth, A. AU - Cooke, T. G. AU - Watters, A. D. AU - Bartlett, J. M. PY - 2004 DA - 2004// TI - Interlaboratory comparison of HER-2 oncogene amplification as detected by chromogenic and fluorescence in situ hybridization JO - Clin Cancer Res VL - 10 UR - https://doi.org/10.1158/1078-0432.CCR-0428-03 DO - 10.1158/1078-0432.CCR-0428-03 ID - Isola2004 ER - TY - JOUR AU - Dowsett, M. AU - Hanna, W. M. AU - Kockx, M. AU - Penault-Llorca, F. AU - Ruschoff, J. AU - Gutjahr, T. AU - Habben, K. AU - van de Vijver, M. J. PY - 2007 DA - 2007// TI - Standardization of HER2 testing: results of an international proficiency-testing ring study JO - Mod Pathol VL - 20 UR - https://doi.org/10.1038/modpathol.3800774 DO - 10.1038/modpathol.3800774 ID - Dowsett2007 ER -